poisar

Stocks · News reference

Achieve Life Sciences To Present 52-Week Cytisinicline Data For Smoking And Vaping Cessation At CHEST 2026 On October 20

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ACHV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — ACHIEVE LIFE SCIENCES, INC. (ACHV)

    Filed: 2026-10-01 AccNo: 0001193125-26-410781 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    ACHV